Condition
Stage IIIB Lung Non-Small Cell Cancer AJCC v7 clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Stage IIIB Lung Non-Small Cell Cancer AJCC v7 clinical trials that are recruiting, in United States. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Combining local therapy and durvalumab for advanced lung cancer after initial treatment
This study is testing whether combining local treatments like surgery or radiation with the immunotherapy durvalumab can help people with advanced lung cancer live longer and feel better after their initial treatment.
-
Using osimertinib to treat lung cancer with specific genetic mutations
This study is testing if a medication called osimertinib can help people with advanced lung cancer that has a specific genetic mutation feel better and live longer.
Related topics
Quick answers
How many Stage IIIB Lung Non-Small Cell Cancer AJCC v7 clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.